Rishita Tiwari
Pediatric Endocrinology · Tucson, AZNPI 1871630228
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 290 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 8.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,210, 5.8 times the $207 reported in 2019.
Across 290 payments — averaging $18.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tolmar, Inc.$462
- Abbott$434
- Xeris Pharmaceuticals, Inc.$423
- Sanofi-aventis U.S. LLC$369
- Insulet Corporation$322
- Arbor Pharmaceuticals, Inc.$292
- plus $3K from 31 others
What the payments were for
- Food & beverage$5,20395%
- Education$2495%
- Entertainment$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tolmar, Inc. | 35 | $462 |
| Abbott | 18 | $434 |
| Xeris Pharmaceuticals, Inc. | 22 | $423 |
| Sanofi-aventis U.S. LLC | 14 | $369 |
| Insulet Corporation | 20 | $322 |
| Arbor Pharmaceuticals, Inc. | 17 | $292 |
| Dexcom, Inc. | 14 | $291 |
| Lilly USA, LLC | 14 | $258 |
| Tolmar Pharmaceuticals, Inc. | 14 | $246 |
| Azurity Pharmaceuticals, Inc. | 11 | $229 |
| Ipsen Biopharmaceuticals, Inc | 11 | $223 |
| BETA Bionics, Inc. | 18 | $193 |
| Ultragenyx Pharmaceutical Inc. | 8 | $186 |
| AbbVie | 9 | $170 |
| Pfizer | 9 | $170 |
| Ascendis Pharma Endocrinology Inc | 7 | $156 |
| Medtronic | 5 | $136 |
| Neurocrine Biosciences, Inc. | 4 | $128 |
| Novo Nordisk | 8 | $116 |
| Kyowa Kirin, Inc. | 4 | $108 |
| Tandem Diabetes Care, Inc. | 5 | $95 |
| Eton Pharmaceuticals, Inc. | 2 | $73 |
| Sequel Med Tech, LLC | 1 | $50 |
| Zealand Pharma US, Inc. | 2 | $41 |
| Bayer | 3 | $40 |
| IBSA Pharma Inc. | 3 | $37 |
| Amphastar Pharmaceuticals, Inc. | 2 | $30 |
| Soleno Therapeutics, Inc. | 1 | $28 |
| Corcept Therapeutics | 1 | $25 |
| Optos, Inc. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Amryt Pharma Holdings Ltd | 1 | $21 |
| Amgen | 1 | $19 |
| Averitas Pharma Inc. | 1 | $17 |
| BD | 1 | $15 |
| Intuity Medical Inc | 1 | $14 |
| Embecta Corp. | 1 | $13 |
How this compares
$5,474 in reported general payments places this provider in the 75th percentile of 35 pediatric endocrinology providers in Arizona.
Other pediatric endocrinology in Tucson
- Chetanbabu PatelTucson$7K
- Priti PatelTucson$5K
- Mark WheelerTucson$494
- Sunil SinhaTucson$330
- Cindy ChinTucson$181
- Sarah GreenTucson$91
- Eileen Baez IrizarryPhoenix$53K
- Pamela SmithPhoenix$26K
- Chirag KapadiaPhoenix$13K
- Grazyna Piekos-SobczakPhoenix$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.